DNA methylation profile during multistage progression of pulmonary adenocarcinomas

Jin Haeng Chung, Hyun Ju Lee, Baek-Hui Kim, Nam Yun Cho, Gyeong Hoon Kang

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Multiple genetic and epigenetic alterations are known to be involved in the carcinogenesis of peripheral pulmonary adenocarcinoma (ADC). However, epigenetic abnormalities have not been extensively investigated in the following multistage progression sequence: atypical adenomatous hyperplasia (AAH) to adenocarcinoma in situ (AIS), to invasive ADC. To determine the potential role of promoter methylation during ADC development of the lung, we examined methylation status in 20 normal, 20 AAH, 30 AIS, and 60 ADC lung tissues and compared methylation status among the lesions. The MethyLight assay was used to determine the methylation status of 18 CpG island loci, which were hypermethylated in ADC compared to noncancerous lung tissues. The mean number of methylated CpG island loci was significantly higher in ADC than in AAH and AIS, (p<0.003 between ADC and AAH, p<0.005 between ADC and AIS). Aberrant methylation of HOXA1, TMEFF2, and RARB was frequently observed in preinvasive lesions, including AAH and AIS. Furthermore, methylation of PENK, BCL2, RUNX3, DLEC1, MT1G, GRIN2B, CDH13, CCND2, and HOXA10 was significantly more frequent in invasive ADC than AAH or AIS. Our results indicate that epigenetic alterations are involved in the multistep progression of pulmonary ADC development, and aberrant CpG island methylation accumulates during multistep carcinogenesis. In addition, aberrant methylation of HOXA1, TMEFF2, and RARB occurred in preinvasive lesions, which indicates that epigenetic alterations of these genes are involved in the early stages of pulmonary ADC development. In contrast, hypermethylation of PENK, BCL2, RUNX3, DLEC1, MT1G, GRIN2B, CDH13, CCND2, and HOXA10 was more frequent in invasive ADC than in preinvasive lesions, which indicates that methylation of these genes occurs later during tumor invasion in the AAH-AIS-ADC sequence.

Original languageEnglish
Pages (from-to)201-211
Number of pages11
JournalVirchows Archiv
Volume459
Issue number2
DOIs
Publication statusPublished - 2011 Aug 1

Fingerprint

DNA Methylation
Methylation
Hyperplasia
Adenocarcinoma
Epigenomics
CpG Islands
Carcinogenesis
Adenocarcinoma of lung
Adenocarcinoma in Situ
Genes
Lung

Keywords

  • Adenocarcinoma
  • AIS
  • CpG island
  • DNA methylation
  • Lung cancer

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Molecular Biology
  • Cell Biology

Cite this

DNA methylation profile during multistage progression of pulmonary adenocarcinomas. / Chung, Jin Haeng; Lee, Hyun Ju; Kim, Baek-Hui; Cho, Nam Yun; Kang, Gyeong Hoon.

In: Virchows Archiv, Vol. 459, No. 2, 01.08.2011, p. 201-211.

Research output: Contribution to journalArticle

Chung, Jin Haeng ; Lee, Hyun Ju ; Kim, Baek-Hui ; Cho, Nam Yun ; Kang, Gyeong Hoon. / DNA methylation profile during multistage progression of pulmonary adenocarcinomas. In: Virchows Archiv. 2011 ; Vol. 459, No. 2. pp. 201-211.
@article{2dff1a307a5742a1b2757978aa1e9513,
title = "DNA methylation profile during multistage progression of pulmonary adenocarcinomas",
abstract = "Multiple genetic and epigenetic alterations are known to be involved in the carcinogenesis of peripheral pulmonary adenocarcinoma (ADC). However, epigenetic abnormalities have not been extensively investigated in the following multistage progression sequence: atypical adenomatous hyperplasia (AAH) to adenocarcinoma in situ (AIS), to invasive ADC. To determine the potential role of promoter methylation during ADC development of the lung, we examined methylation status in 20 normal, 20 AAH, 30 AIS, and 60 ADC lung tissues and compared methylation status among the lesions. The MethyLight assay was used to determine the methylation status of 18 CpG island loci, which were hypermethylated in ADC compared to noncancerous lung tissues. The mean number of methylated CpG island loci was significantly higher in ADC than in AAH and AIS, (p<0.003 between ADC and AAH, p<0.005 between ADC and AIS). Aberrant methylation of HOXA1, TMEFF2, and RARB was frequently observed in preinvasive lesions, including AAH and AIS. Furthermore, methylation of PENK, BCL2, RUNX3, DLEC1, MT1G, GRIN2B, CDH13, CCND2, and HOXA10 was significantly more frequent in invasive ADC than AAH or AIS. Our results indicate that epigenetic alterations are involved in the multistep progression of pulmonary ADC development, and aberrant CpG island methylation accumulates during multistep carcinogenesis. In addition, aberrant methylation of HOXA1, TMEFF2, and RARB occurred in preinvasive lesions, which indicates that epigenetic alterations of these genes are involved in the early stages of pulmonary ADC development. In contrast, hypermethylation of PENK, BCL2, RUNX3, DLEC1, MT1G, GRIN2B, CDH13, CCND2, and HOXA10 was more frequent in invasive ADC than in preinvasive lesions, which indicates that methylation of these genes occurs later during tumor invasion in the AAH-AIS-ADC sequence.",
keywords = "Adenocarcinoma, AIS, CpG island, DNA methylation, Lung cancer",
author = "Chung, {Jin Haeng} and Lee, {Hyun Ju} and Baek-Hui Kim and Cho, {Nam Yun} and Kang, {Gyeong Hoon}",
year = "2011",
month = "8",
day = "1",
doi = "10.1007/s00428-011-1079-9",
language = "English",
volume = "459",
pages = "201--211",
journal = "Virchows Archiv",
issn = "0945-6317",
publisher = "Springer Verlag",
number = "2",

}

TY - JOUR

T1 - DNA methylation profile during multistage progression of pulmonary adenocarcinomas

AU - Chung, Jin Haeng

AU - Lee, Hyun Ju

AU - Kim, Baek-Hui

AU - Cho, Nam Yun

AU - Kang, Gyeong Hoon

PY - 2011/8/1

Y1 - 2011/8/1

N2 - Multiple genetic and epigenetic alterations are known to be involved in the carcinogenesis of peripheral pulmonary adenocarcinoma (ADC). However, epigenetic abnormalities have not been extensively investigated in the following multistage progression sequence: atypical adenomatous hyperplasia (AAH) to adenocarcinoma in situ (AIS), to invasive ADC. To determine the potential role of promoter methylation during ADC development of the lung, we examined methylation status in 20 normal, 20 AAH, 30 AIS, and 60 ADC lung tissues and compared methylation status among the lesions. The MethyLight assay was used to determine the methylation status of 18 CpG island loci, which were hypermethylated in ADC compared to noncancerous lung tissues. The mean number of methylated CpG island loci was significantly higher in ADC than in AAH and AIS, (p<0.003 between ADC and AAH, p<0.005 between ADC and AIS). Aberrant methylation of HOXA1, TMEFF2, and RARB was frequently observed in preinvasive lesions, including AAH and AIS. Furthermore, methylation of PENK, BCL2, RUNX3, DLEC1, MT1G, GRIN2B, CDH13, CCND2, and HOXA10 was significantly more frequent in invasive ADC than AAH or AIS. Our results indicate that epigenetic alterations are involved in the multistep progression of pulmonary ADC development, and aberrant CpG island methylation accumulates during multistep carcinogenesis. In addition, aberrant methylation of HOXA1, TMEFF2, and RARB occurred in preinvasive lesions, which indicates that epigenetic alterations of these genes are involved in the early stages of pulmonary ADC development. In contrast, hypermethylation of PENK, BCL2, RUNX3, DLEC1, MT1G, GRIN2B, CDH13, CCND2, and HOXA10 was more frequent in invasive ADC than in preinvasive lesions, which indicates that methylation of these genes occurs later during tumor invasion in the AAH-AIS-ADC sequence.

AB - Multiple genetic and epigenetic alterations are known to be involved in the carcinogenesis of peripheral pulmonary adenocarcinoma (ADC). However, epigenetic abnormalities have not been extensively investigated in the following multistage progression sequence: atypical adenomatous hyperplasia (AAH) to adenocarcinoma in situ (AIS), to invasive ADC. To determine the potential role of promoter methylation during ADC development of the lung, we examined methylation status in 20 normal, 20 AAH, 30 AIS, and 60 ADC lung tissues and compared methylation status among the lesions. The MethyLight assay was used to determine the methylation status of 18 CpG island loci, which were hypermethylated in ADC compared to noncancerous lung tissues. The mean number of methylated CpG island loci was significantly higher in ADC than in AAH and AIS, (p<0.003 between ADC and AAH, p<0.005 between ADC and AIS). Aberrant methylation of HOXA1, TMEFF2, and RARB was frequently observed in preinvasive lesions, including AAH and AIS. Furthermore, methylation of PENK, BCL2, RUNX3, DLEC1, MT1G, GRIN2B, CDH13, CCND2, and HOXA10 was significantly more frequent in invasive ADC than AAH or AIS. Our results indicate that epigenetic alterations are involved in the multistep progression of pulmonary ADC development, and aberrant CpG island methylation accumulates during multistep carcinogenesis. In addition, aberrant methylation of HOXA1, TMEFF2, and RARB occurred in preinvasive lesions, which indicates that epigenetic alterations of these genes are involved in the early stages of pulmonary ADC development. In contrast, hypermethylation of PENK, BCL2, RUNX3, DLEC1, MT1G, GRIN2B, CDH13, CCND2, and HOXA10 was more frequent in invasive ADC than in preinvasive lesions, which indicates that methylation of these genes occurs later during tumor invasion in the AAH-AIS-ADC sequence.

KW - Adenocarcinoma

KW - AIS

KW - CpG island

KW - DNA methylation

KW - Lung cancer

UR - http://www.scopus.com/inward/record.url?scp=80052424755&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052424755&partnerID=8YFLogxK

U2 - 10.1007/s00428-011-1079-9

DO - 10.1007/s00428-011-1079-9

M3 - Article

C2 - 21494759

AN - SCOPUS:80052424755

VL - 459

SP - 201

EP - 211

JO - Virchows Archiv

JF - Virchows Archiv

SN - 0945-6317

IS - 2

ER -